Business Description
Zelluna ASA
ISIN : NO0013524942
Share Class Description:
OSTO:ULTIo: Ordinary SharesTotal Employee Number:
15Description
Zelluna ASA is a biotechnology company established to eliminate solid cancers by unleashing the powerful elements of the immune system through pioneering the development of T cell receptor (TCR) guided natural killer (NK) cell therapies (TCR-NK). Its TCR-NK products are composed of healthy donor-derived NK cells that are genetically engineered to express a tumour-specific TCR that enable the TCR-NK cells to identify and eliminate cancer cells in the body of the patient. Its programme ZI-MA4-1, the first MAGE-A4-targeting TCR-NK therapy for solid tumours with high unmet medical need. Its other programmes include ZI-KL1-1, and ZI-PR-1.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 139.79 | |||||
Equity-to-Asset | 0.88 | |||||
Debt-to-Equity | 0.01 | |||||
Piotroski F-Score | 3/9 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 49.4 | |||||
3-Year EPS without NRI Growth Rate | 48 | |||||
3-Year FCF Growth Rate | 46.5 | |||||
3-Year Book Growth Rate | -55.6 |
Momentum Rank
9/10
| Name | Current | Vs Industry | Vs History |
|---|
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 6.7 | |||||
Quick Ratio | 6.7 | |||||
Cash Ratio | 5.61 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -96.9 | |||||
Shareholder Yield % | 0.28 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
ROE % | -101.26 | |||||
ROA % | -87.92 | |||||
ROIC % | -149.98 | |||||
3-Year ROIIC % | 21.92 | |||||
ROC (Joel Greenblatt) % | -3613.2 | |||||
ROCE % | -100.59 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Forward PE Ratio | 87.8 | |||||
PB Ratio | 7.29 | |||||
Price-to-Tangible-Book | 9.22 | |||||
EV-to-EBIT | -3.4 | |||||
EV-to-EBITDA | -3.54 | |||||
EV-to-Forward-EBITDA | -0.33 | |||||
EV-to-FCF | -3.09 | |||||
| Price-to-Net-Current-Asset-Value | 9.76 | |||||
| Price-to-Net-Cash | 12.06 | |||||
Earnings Yield (Greenblatt) % | -29.4 | |||||
FCF Yield % | -28.79 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Zelluna ASA Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil kr) | |||
| EPS (TTM) (kr) | -6 | ||
| Beta | -0.4499 | ||
| 3-Year Sharpe Ratio | -0.61 | ||
| 3-Year Sortino Ratio | -0.65 | ||
| Volatility % | - | ||
| 14-Day RSI | - | ||
| 14-Day ATR (kr) | - | ||
| 20-Day SMA (kr) | 21.95 | ||
| 12-1 Month Momentum % | - | ||
| 52-Week Range (kr) | 21.95 - 21.95 | ||
| Shares Outstanding (Mil) | 26.27 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Zelluna ASA Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Zelluna ASA Stock Events
| Event | Date | Price (kr) | ||
|---|---|---|---|---|
| Third quarter earnings conference call for 2026 | 2026-11-06 | In 127 days | ||
| Third quarter earnings results for 2026 | 2026-11-06 | In 127 days | ||
| Third quarter earnings conference call for 2026 | 2026-11-05 | In 126 days | ||
| Third quarter earnings results for 2026 | 2026-11-05 | In 126 days | ||
| Second quarter earnings conference call for 2026 | 2026-08-21 | In 50 days | ||
| Second quarter earnings results for 2026 | 2026-08-21 | In 50 days | ||
| Second quarter earnings conference call for 2026 | 2026-08-20 | In 49 days | ||
| Second quarter earnings results for 2026 | 2026-08-20 | In 49 days | ||
| First quarter earnings conference call for 2026 | 2026-05-08 | 21.95 (+0.00%) | ||
| First quarter earnings results for 2026 | 2026-05-08 | 21.95 (+0.00%) |
Show
Entries
Zelluna ASA Frequently Asked Questions
What is Zelluna ASA(OSTO:ULTIo)'s stock price today?
The current price of OSTO:ULTIo is kr21.95. The 52 week high of OSTO:ULTIo is kr21.95 and 52 week low is kr21.95.
When is next earnings date of Zelluna ASA(OSTO:ULTIo)?
The next earnings date of Zelluna ASA(OSTO:ULTIo) is 2026-08-20.
Does Zelluna ASA(OSTO:ULTIo) pay dividends? If so, how much?
Zelluna ASA(OSTO:ULTIo) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Zelluna ASA
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers